West Hill Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History

West Hill Financial Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$47.98 - $54.4 $2,782 - $3,155	58 Added 1.4%	4,206 $228,000
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $2,230 - $2,661	-46 Reduced 1.1%	4,148 $212,000
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $1,910 - $2,136	33 Added 0.79%	4,194 $243,000
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $2,293 - $2,546	-36 Reduced 0.86%	4,161 $266,000
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $32,855 - $37,265	-500 Reduced 10.65%	4,197 $290,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $34,240 - $40,545	500 Added 11.91%	4,697 $337,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $3 - $2,074	27 Added 0.65%	4,197 $298,000
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $1,815 - $1,999	25 Added 0.6%	4,170 $321,000
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $36,888 - $44,232	-600 Reduced 12.64%	4,145 $303,000
Q1 2021 Oct 13, 2021	SELL	$59.34 - $66.74 $356 - $400	-6 Reduced 0.13%	4,745 $300,000
Q4 2020 Feb 17, 2021	BUY	$57.74 - $65.43 $274,322 - $310,857	4,751 New	4,751 $295,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of West Hill Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on West Hill Financial Advisors, Inc. with notifications on news.